(Reuters) -The U.S. health regulator on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year. The Food and Drug Administration’s advisory is in line with European and World Health Organization recommendations and comes after the agency’s advisers on Wednesday overwhelmingly […]
The expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in favor of selecting the JN.1 COVID-19 subvariant to be targeted by the next round of COVID-19 vaccines this fall. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) was asked if it would recommended a monovalent vaccine that targets […]
WASHINGTON (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus called JN.1. While COVID-19 cases currently are low, more surges are inevitable and manufacturers need time to brew shots for fall. Moderna, Pfizer and […]
A panel of health experts convened this week to decide which vaccine the U.S. should use against COVID-19 this fall. The federal advisory group decided on Wednesday the new vaccine should focus on the JN.1 lineage that has dominated virus strains in recommendations. The Vaccines and Related Biological Products Advisory Committee – composed of leading […]
(Reuters) – COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1 variant that was dominant earlier this year could neutralize newer subvariants such as KP.2 much better than the older shots. This was disclosed in presentations by the companies ahead of a meeting of the U.S. Food and Drug […]
(Reuters) -Vaccine makers should consider targeting one of the currently dominant JN.1 variants and JN.1-derived subvariants such as KP.2 as they develop COVID-19 shots for the 2024-2025 campaign, the U.S. Food and Drug Administration’s staff said on Monday. The FDA reviewers said since the difference between JN.1 and newer subvariants such as KP.2 subvariants is […]
A lot has changed since SARS-CoV-2 (the virus responsible for COVID-19) appeared on the world stage four years ago. In 2020 the novel coronavirus infected and upended the daily lives of millions of people, but today life has mostly returned to normal: Restrictions have been lifted, people are a lot less cautious, and the etiquette […]
Close to all new COVID-19 cases in the United States are now being caused by the JN.1 variant, the Centers for Disease Control and Prevention says, with an estimated 93.1% of infections now blamed on the highly mutated strain. The CDC’s latest biweekly estimate of the variant’s spread was published Friday. It comes as key trends […]
A shot of the latest Covid-19 vaccine can help cut the chances of getting a symptomatic infection by half, early data from the US Centers for Disease Control and Prevention suggests. Vaccine manufacturers updated their formulations to target the Omicron variant XBB.1.5, which was the predominant circulating strain for much of 2023. But the new […]
Early data from hospitals suggests the latest COVID variant, known as JN.1, is not leading to more severe disease, a Centers for Disease Control and Prevention official said Monday, as the agency has tracked the strain’s steep rise to an estimated 85.7% of COVID-19 cases nationwide. The agency is still waiting for more weeks of […]
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Monday estimated COVID subvariant JN.1 to account for about 85.7% of cases in the United States, as of Jan. 19. The agency said JN.1 remains the most widely circulating variant of SARS-CoV-2 in the country and globally. There is no evidence at present […]
You—or your child—have body aches, fever, and cough. Is it RSV, COVID, the flu, a common cold, or something else? And does it even matter anymore? Unfortunately, it’s impossible to definitively tell the conditions apart without testing—even by cough, experts tell Fortune. But the answer will still matter, if your condition is severe and a […]